Bin Feng

Chinese Academy of Medical Sciences & Peking Union Medical College — China

Medicine · Health Sciences

11h-index1.8kcitations165works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

PARP inhibition in cancer therapy(96), Cancer, Lipids, and Metabolism(32), Lipoproteins and Cardiovascular Health(31), Biosimilars and Bioanalytical Methods(18), Health Systems, Economic Evaluations, Quality of Life(12)

Publications165 total

Effectiveness and safety of intraosseous regional administration versus intravenous tranexamic acid in primary total knee arthroplasty: a randomized, triple-blind, placebo-controlled trial
International Journal of Surgery·2025Open Access
Balanced T helper 17/regulatory T cells in gut–lung axis improve chronic obstructive pulmonary disease: The benefits of Polygonatum sibiricum polysaccharide
Chinese Medical Journal·2025Open Access
Herbal analgesic patches versus NSAIDs in soft tissue injury management: real-world comparative effectiveness from a 35-center Chinese prospective cohort of 1378 participants
International Journal of Surgery·2025Open Access
A novel TRPV4 variant in spondylometaphyseal dysplasia, kozlowski type reveals a previously unreported loss-of-function mechanism
Orphanet Journal of Rare Diseases·2025Open Access
Relationship between stroke injury sites and incidence of post-stroke pain: a systematic review and meta-analysis
Systematic Reviews·2025Open Access
Exosome-integrated biomaterials: A paradigm in musculoskeletal regeneration
Cell Reports Physical Science·2025· 2 citedOpen Access
Exosome-Based Therapeutics for Musculoskeletal Disorders: Advances in Engineering, Targeting, and Biomaterial Integration
ACS Nano·2025· 3 citedOpen Access
Two-dimensional nanomaterials for bone disease therapy: multifunctional platforms for regeneration, anti-infection and tumor ablation
Journal of Nanobiotechnology·2025· 3 citedOpen Access
NEK2 regulates B cell function and the severity of experimental autoimmune encephalomyelitis
Journal of Neuroinflammation·2025Open Access
Table S5 from Potential Synergistic Effect between Niraparib and Statins in Ovarian Cancer Clinical Trials
2025Open Access
Table S8 from Potential Synergistic Effect between Niraparib and Statins in Ovarian Cancer Clinical Trials
2025Open Access
Figure S3 from Potential Synergistic Effect between Niraparib and Statins in Ovarian Cancer Clinical Trials
2025Open Access
Table S1 from Potential Synergistic Effect between Niraparib and Statins in Ovarian Cancer Clinical Trials
2025Open Access
Table S7 from Potential Synergistic Effect between Niraparib and Statins in Ovarian Cancer Clinical Trials
2025Open Access
Table S6 from Potential Synergistic Effect between Niraparib and Statins in Ovarian Cancer Clinical Trials
2025Open Access
Figure S1 from Potential Synergistic Effect between Niraparib and Statins in Ovarian Cancer Clinical Trials
2025Open Access
Table S3 from Potential Synergistic Effect between Niraparib and Statins in Ovarian Cancer Clinical Trials
2025Open Access
Table S2 from Potential Synergistic Effect between Niraparib and Statins in Ovarian Cancer Clinical Trials
2025Open Access
Figure S4 from Potential Synergistic Effect between Niraparib and Statins in Ovarian Cancer Clinical Trials
2025Open Access
Table S4 from Potential Synergistic Effect between Niraparib and Statins in Ovarian Cancer Clinical Trials
2025Open Access
page 1 of 9Next →

Frequent Co-authors

Mansoor Raza Mirza(8), Antonio González-Martı́n(7), Anna Rutkowska(6), Giovanna Bergamini(6), Hailei Zhang(5), Xisheng Weng(5), Xing-Dong Yang(5), Gordon B. Mills(4), Zebin Wang(4), Ursula A. Matulonis(4), Kevin Coleman(4), Zehui Lv(4), Xuejie Cai(4), Bradley J. Monk(4), Ignace Vergote(4), Bhavana Pothuri(4), Whitney A. Spannuth Graybill(4), Carsten Goessel(4), Olena Barbash(4), Yonghong Xiao(3)